Abstract
Purpose: Development of acute kidney injury (AKI) in patients undergoing cardiac surgery leads to worse outcomes. Emerging biomarkers of AKI, such as cystatin C (CysC) and neutrophil gelatinase-associated lipocalin (NGAL) can only predict AKI, at best, 1–2 hours after surgery. Monitoring of intraoperative urinary PO2 (UPO2) may predict AKI earlier than available biomarkers. This may facilitate intervention to prevent postoperative AKI. Thus, we compared UPO2 with several emerging biomarkers of AKI in adult patients undergoing on-pump cardiac surgery.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
